Topic List 2 - Urooncology Flashcards
(37 cards)
Groups of antineoplastic drugs - Kidney tumors
Not sensitive to chemotherapy
Immunotherapy: Interferon alpha2, IL-2
Targeted therapy: VEGF blocking drugs
Groups of antineoplastic drugs - tumors of pyelon and ureter
Gemzar-cisplatin
M-VAC: Methotrexate, Vinblastine, Adriamycin, Cisplatin
Groups of antineoplastic drugs - Bladder
Superficial bladder cancer
- Mitomycin C, Epirubicin, Doxorubicin
Invasive bladder cancer
- M-VAC: Methotrexate Vinblastine, Adriamycin, Cisplatin
- Gemzar- cisplatin
Immunotherapy after TURB: BCG vaccine (Super weird, but makes it memorable)
Groups of antineoplastic drugs - Prostate
Advanced Disease:
Hormonal therapy:
1. Antiandrogens: Flutamide
2. LHRH agonist: Triptorelin
Chemotherapy:
3. Docetaxel/Cabazitaxel
Secondary hormonal therapy:
4. Abiraterone
5. Enzalutamide
Bone metastasis:
6. Alpharadin irradiation
7. Bisphosphonates
Groups of antineoplastic drugs - Testes
Chemotherapy if vascular or lymphatic invasion:
- BEP: Bleomycin, Etoposide, Cisplatin
- PVB: Cisplatin, Vinblastine, Bleomycin
Groups of antineoplastic drugs - Penis
Chemotherapy:
- Vincristine, MTX, Bleomycin, 5-FU, Cisplatin
Groups of antineoplastic drugs - Alkylating agents
- Bleomycin - intercalating
- Cisplatin - platinum
Groups of antineoplastic drugs - Antimetabolites
- Methotrexate - Folate
- 5-FU - Pyrimidine analogues
Groups of antineoplastic drugs - Topoisomerase inhibitors
- Doxorubicin
- Epirubicin
Groups of antineoplastic drugs - Mitotic spindle inhibitors
- Vincristine/Vinblastine - Vinca alkaloids
- Docetaxel - Taxanes
What are benign tumors of the kidney
- Angiomyolipoma
- Adenoma
- Oncocytoma
What are malignant tumors of the kidney
- Adenocarcinoma (82%)
- Clear cell, papillary, chromophobe, bellini tumor - Sarcoma
- Lymphoma
What is the classic triad of Renal cell carcinoma?
- Hematuria
- Flank pain
- Palpable abdominal mass
Only 10-15% of the patients present like this though
Kidney tumors - Treatment
- Surgery (first choice) Most important by far
- Immune therapy: Alpha2 interferon, IL-2
- Chemotherapy: Vinblastine, 5-FU
- Bisphosphonate therapy
Kidney tumors - typical areas of metastasis
Lung, liver, brain, bone
Kidney tumor specific - classifications
Robson’s
Fuhrmann
Tumors of the pyelon and ureter
10% of renal tumors and 5% of urothelial tumors
Peak incidence: 70-90 years old; smoking
Hereditary: HNPCC
60% are invasive
Superficial bladder cancer - types (histology)
- Transitional cell carcinoma (90%)
- Adenocarcinoma (3-4%)
- SCC (2-3%)
- Rhabdomyosarcome, leiomyosarcome, lymphoma, melanoma (<1%)
Bladder cancer diagnosis
- History: Painless hematuria, irritative symptoms (frequency, urgency, dysuria)
- Physical: Nothing unless super advanced
- Labs: Urinalysis, Anemia, SeCr/SeUr increased
- US
- Cystoscopy
- CT
- MRI
8.Urine cytology
Superficial Bladder cancer - Treatment
- TURB
- Adjuvant treatment - intravesical instillation
- indications: Rapid tumor recurrence, multicentricity, invasion, presence of carcinoma in-situ - Chemotherapy - Mitomycin C, Epirubicin, Doxorubicin
Invasive Bladder Cancer (T2 and up) - Treatment
- Radical cystectomy
-Males: Bladder + prostate + vesicles + parailiac lymph are removed
-Females: Bladder + uterus + upper third of vagina are removed - Urinary deviation: Percutaneous nephrostomy or ureterocutaneostomy
- Chemotherapy:
-M-VAC (methotrexate, vinblastine, adriamycin, cisplatin)
-Gemzar-cisplatin
Prostate cancer - Epidemiology and Etiology
Epidemiology:
-Hungary 4500 each year, 1400 die
Etiology:
-Genetics
-Hormonal
-Environmental
Prostate cancer scoring system
Gleason score: Based on histology glandular formation
Well differentiated 1-3
Medium 4-7
Poor differentiation 8-10
Prostate cancer diagnosis
- DRE
- PSA
- Transrectal US (80% nothing can be seen on US)
- Biopsy (6 samples each lobe, 12 total)
- MRI
- PCA3 (prostate cancer antigen 3)